FDA Approved: RALOXIFENE HYDROCHLORIDE — Original Application (ScieGen Pharmaceuticals Inc)

View source ↗

Summary

FDA approves the original application for raloxifene hydrochloride from ScieGen Pharmaceuticals Inc, providing a generic option for postmenopausal osteoporosis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Breast Cancer
• Postmenopausal Osteoporosis

Drugs mentioned

• RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)

Snippet

ORIG AP for RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)